Yuval Peled


Practice Areas


Contact Details

T +972.3.6944111
F +972.3.609.1116

vCardDownload as PDF

Mr. Peled is a partner in FBC’s Tax practice.

His practice focuses on international tax matters, and regularly advises on the tax aspects of mergers and acquisitions, investment funds, reorganizations, and financing.

Mr. Peled represents private clients in developing and implementing sophisticated domestic and international tax and estate plans and advises on the tax aspects of trusts.

Before joining FBC, Mr. Peled spent three years working as a tax lawyer in the New York office of Ropes & Gray LLP, and prior to that worked as a CPA at Deloitte Israel.

Mr. Peled received an LL.M. in International Taxation from the University of Michigan.

New York, 2016

Israel, 2011

CPA (Israel), 2014

University of Michigan, LL.M., (International Taxation), 2015

Tel Aviv University, LL.B. (Law and Accounting), 2011

Representation of Tower Semiconductor Ltd. in its acquisition by Intel, at a value of $5.4 billion (!)

Mega deal right out of the gate in 2022! We are excited to share that our firm has had the honor of representing our long-standing client, Tower Semiconductor Ltd., the Israeli chipmaker, in its acquisition by Intel, at a value of $5.4 billion (!) This deal is one of ...

Avraham Well & Sharon Rosen & Ron Sitton & Nitzan Sandor & Yuval Peled & Tal Eyal-Boger & Ziv Schwartz & Moran Friedman & Etti Dolev & Omri Rachum-Twaig, Dr. & Audrey Abensur & Yahel Arckens | Mar 2022

Representation of J.P. Morgan in the Private Offering by Fiverr International Ltd. (NYSE: FVRR) of Convertible Senior Notes

Representation of J.P. Morgan as Lead Left Bookrunner and representative of the initial purchasers in the private offering by Fiverr International Ltd. (Nasdaq: FVRR) of $460 million of 0% Convertible Senior Notes due 2025 (including the exercise in full of the overallo...

Eran Yaniv & Sharon Rosen & Anat Shavit & Yuval Peled & Omri Rachum-Twaig, Dr. & Gal Doitch | Jan 2021

Representation of Luminera Derm in the Sale of its Dermal Business to AbbVie

Representation of Luminera Derm Ltd. and its affiliated companies in a share and asset transaction, pursuant to which Luminera sold its dermal filler portfolio and R&D pipeline to AbbVie Inc. (NYSE: ABBV) unit Allergan Aesthetics, for a consideration of hundreds of ...

Raz Tepper & Sharon Klein-Manbar & Anat Shavit & Ziv Schwartz & Sharona Haim Pour - Abramovich & Yuval Peled & Ben Strauss & Hila Zackay & Audrey Abensur & Shaul Mizrahi & Moran Friedman | Oct 2020
Related News & Publications >>